Critical Path for Alzheimer's Disease Database (CPAD Database)
The CPAD Database is based in the United States of America and Netherlands, and contains patient-level data from over 12,000 patients across 36 clinical trials of Alzheimer's disease and Mild cognitive impairment. All data are full de-identified, and have been remapped to a common data standard such that all the data can be analysed across all studies.
Study design
Registry
Number of participants at first data collection
12,811 (participants)
Recruitment is ongoing
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2019
Primary Institutions
Critical Path Institute
Profile paper DOI
Not available
Funders
No funding information available
Ongoing?
Yes
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Electroencephalography (EEG)
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- None
Engagement
Keywords
Consortia and dataset groups
